Estimates risk of cardiac complications after noncardiac surgery
Audience: PRACTITIONER
Published by EVAL Foundation
Revision 3 · Published August 1, 2024
The Revised Cardiac Risk Index (RCRI) for pre-operative risk allows the clinician in the inpatient or outpatient preoperative setting to risk-stratify patients before undergoing a procedure or surgery. However, the score is not as well validated in emergency surgery patients. RCRI can also be a tool to help patients understand their individual risk profile as a part of an informed consent conversation. When patients present with elevated risk (RCRI ≥ 1, age ≥ 65, or age 45-64 with significant cardiovascular disease), additional preoperative risk stratification is provided (e.g. serum NT-proBNP or BNP) along with post-op cardiac monitoring recommendations (e.g. EKG, troponins). The RCRI has been validated by multiple studies. A large 2010 systematic review found moderate discrimination in predicting major perioperative cardiac complications (Ford, 2010). According to Duceppe (2017), other perioperative cardiac risk scores, such as the Myocardial Infarction and Cardiac Arrest (MICA) Score and the American College of Surgeons (ACS) National Surgical Quality Improvement Program (NSQIP) Score, have only been retrospectively validates and likely underestimates the risk of myocardial ischemia.
.The Revised Cardiac Risk Index (RCRI) is intended for the following population undergoing elective non-cardiac surgery or urgent/semi-urgent (non-emergent) non-cardiac surgery:
*Significant cardiac disease refers to a known history of
| Risk Factor | Description | Points |
| Elevated-risk surgery* | Examples: intraperitoneal, intrathoracic, suprainguinal, carotid, head and neck, orthopedic, prostate, vascular (aortic and major vascular) | 1 |
| History of ischemic heart disease | History of myocardial infarction (MI); history of positive exercise test; current chest pain considered due to myocardial ischemia; use of nitrate therapy or ECG with pathological Q waves | 1 |
| History of congestive heart failure | Pulmonary edema, bilateral rales or S3 gallop; paroxysmal nocturnal dyspnea; chest X-ray (CXR) showing pulmonary vascular redistribution | 1 |
| History of cerebral vascular disease | Prior transient ischemic attack (TIA) or stroke | 1 |
| Pre-operative treatment with insulin | 1 | |
| Pre-operative creatinine > 2 mg/dL or 176.8 µmol/L | 1 |
| RCRI Score | Risk of major cardiac event (95% CI)* |
| 0 | 3.9% (2.8-5.4%) |
| 1 | 6.0% (4.9-7.4%) |
| 2 | 10.1% (8.1-12.6%) |
| ≥ 3 | 15% (11.1-20.0%) |
*Defined as death, myocardial infarction, or cardiac arrest at 30 days after noncardiac surgery (Duceppe, 2017).
Management Considerations
One or more of the following criteria have been met:
According to the 2016 CCS Perioperative Guidelines:
Current: Revision 3
About this evaluation